<DOC>
	<DOCNO>NCT01266148</DOCNO>
	<brief_summary>A control , randomize , open-label , multicenter study evaluate early initiation everolimus early elimination cyclosporine de novo heart transplant recipient improve long-term renal function slow progression chronic allograft vasculopathy</brief_summary>
	<brief_title>SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor ( CNI ) Avoidance</brief_title>
	<detailed_description>This prospective , multi-center , randomize , control , parallel group , open label study de novo heart transplant recipient . Patients eligibility randomization assess 5 day heart transplant.. Patients fulfil inclusion exclusion criterion randomize one two treatment group : either conventional treatment Cyclosporine A ( CsA ) , Mycophenolate mofetil ( MMF ) , corticosteroid ( Group A ) , low-dose CsA everolimus , reduce dose MMF , corticosteroid ( Group B ) . After 7 11 week , CsA discontinue Group B , standard triple-drug immunosuppressive regimen maintain Group A .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>De novo heart transplant recipient receive induction therapy antithomocyte globulin ( ATG ) eligible inclusion . Recipients multiorgan transplant previous transplant exclude , donor age &gt; 70 year , cold ischemia time &gt; 6 hour , patient severe systemic infection , recipient ABO incompatible transplant , patient severe hypercholesterolemia ( &gt; 350mg/dL ) hypertriglyceridemia ( &gt; 750 mg/dL ) , patient past ( &lt; 5 year ) . In order continue study week 711 ( period 1 ) , patient complete first 711 week randomize immunosuppression none follow criterion present : Ongoing rejection treatment experience one grade 3R rejection two grade 2R rejection first 711 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>